Literature DB >> 31000080

Accuracy and stability of deep inspiration breath hold in gated breast radiotherapy - A comparison of two tracking and guidance systems.

Alan M Kalet1, Ning Cao2, Wade P Smith3, Lori Young2, Landon Wootton2, Rob D Stewart3, L Christine Fang2, Janice Kim2, Tony Horton4, Juergen Meyer2.   

Abstract

PURPOSE: To characterize reproducibility of patient breath-hold positioning and compare tracking system performance for Deep Inspiration Breath Hold (DIBH) gated left breast radiotherapy.
METHODS: 29 consecutive left breast DIBH patients (655 fractions) were treated under the guidance of Calypso surface beacons with audio-feedback and 35 consecutive patients (631 fractions) were treated using C-RAD Catalyst HD surface imaging with audiovisual feedback. The Calypso system tracks a centroid determined by two radio-frequency transponders, with a manually enforced institutional tolerance, while the surface image based CatalystHD system utilizes real-time biometric feedback to track a pre-selected point with an institutional tolerance enforced by the Elekta Response gating interface. DIBH motion data from Calypso was extracted to obtain the displacement of breath hold marker in ant/post direction from a set-zero reference point. Ant/post point displacement data from CatalystHD was interpreted by computing the difference between raw tracking points and the center of individual gating windows. Mean overall errors were compared using Welsh's unequal variance t-test. Wilcoxon rank sum test were used for statistical analysis with P < 0.05 considered significant.
RESULTS: Mean overall error for Calypso and CatalystHD were 0.33 ± 1.17 mm and 0.22 ± 0.43 mm, respectively, with t-test comparison P-value < 0.034. Absolute errors for Calypso and CatalystHD were 0.95 ± 0.75 mm and 0.38 ± 0.30 mm, respectively, with Wilcoxon rank sum test P-value <2×10-16. Average standard deviation per fraction was found to be 0.74 ± 0.44 mm for Calypso patients versus 0.54 ± 0.22 mm for CatalystHD.
CONCLUSION: Reduced error distribution widths in overall positioning, deviation of position, and per fraction deviation suggest that the use of functionalities available in CatalystHD such as audiovisual biofeedback and patient surface matching improves accuracy and stability during DIBH gated left breast radiotherapy.
Copyright © 2019 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biofeedback; Motion management; Surface imaging

Mesh:

Year:  2019        PMID: 31000080     DOI: 10.1016/j.ejmp.2019.03.025

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  4 in total

1.  Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer.

Authors:  D Reitz; F Walter; S Schönecker; P Freislederer; M Pazos; M Niyazi; G Landry; F Alongi; E Bölke; C Matuschek; M Reiner; C Belka; S Corradini
Journal:  Radiat Oncol       Date:  2020-05-24       Impact factor: 3.481

2.  Evaluation of image-guided and surface-guided radiotherapy for breast cancer patients treated in deep inspiration breath-hold: A single institution experience.

Authors:  Joan Penninkhof; Kimm Fremeijer; Kirsten Offereins-van Harten; Cynthia van Wanrooij; Sandra Quint; Britt Kunnen; Nienke Hoffmans-Holtzer; Annemarie Swaak; Margreet Baaijens; Maarten Dirkx
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2022-02-17

3.  First clinical experience with real-time portal imaging-based breath-hold monitoring in tangential breast radiotherapy.

Authors:  Elena N Vasina; Natalie Kong; Peter Greer; Jose Baeza Ortega; Tomas Kron; Joanna J Ludbrook; David Thwaites; Joerg Lehmann
Journal:  Phys Imaging Radiat Oncol       Date:  2022-08-13

Review 4.  AAPM task group report 302: Surface-guided radiotherapy.

Authors:  Hania A Al-Hallaq; Laura Cerviño; Alonso N Gutierrez; Amanda Havnen-Smith; Susan A Higgins; Malin Kügele; Laura Padilla; Todd Pawlicki; Nicholas Remmes; Koren Smith; Xiaoli Tang; Wolfgang A Tomé
Journal:  Med Phys       Date:  2022-03-15       Impact factor: 4.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.